Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The researchers propose the use of mifepristone as an alternative way to test for Central
Adrenal Insufficiency (CAI). They want to assess the feasibility of recruitment and the
efficacy of the purposed method.